Global News | World latest News| Trending News
Newswise — William Moss, MD, MPH, a professor at the Johns Hopkins Bloomberg School of Public Health, is available to speak about the rising number of cases of measles in the U.S. Journalists are also welcome to quote from this Q&A with Dr. Moss. The Texas Department of State Health Services on Wednesday reported the…
Newswise — HOUSTON ― Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. According to preclinical results published today in Nature Cancer, the new approach combined the benefits of more well-known antibody-drug conjugates (ADCs) with those of immunotherapies. ADCs have…
Newswise — PHILADELPHIA – A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Viruses, physical trauma, or other problems can have serious impact on lungs, and when the damage is in the lower regions, traditional…
Newswise — New York, NY [February 17, 2025]—Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature of the blood-brain barrier. The findings, in mouse models…
Newswise — Université de Montréal medical professors Nicolas Chomont and Andrés Finzi have secured $5.75 million over five years from the Canadian Institutes of Health Research to try to develop a treatment capable of permanently eliminating HIV from the body. The projects led by Chomont and Finzi, both professors in the Department of Microbiology, Infectiology,…
Newswise — The Institute for Research in Immunology and Cancer of the Université de Montréal (IRIC) high-throughput screening platform has been awarded $583,654 by Quebec’s Ministère de l’Économie, de l’Innovation et de l’Énergie, following a call for projects launched as part of the Quebec Research and Innovation Investment Strategy 2022-2027 (SQRI2). The funded project aims…
Newswise — HOUSTON-(Jan. 21, 2025) – Houston Methodist researchers have identified a key protein as a potential therapeutic target for stopping the body’s immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and allergies. The paper titled “Apex1 safeguards genomic stability to ensure a cytopathic T cell fate in autoimmune disease…
RESEARCH SUMMARY Newswise — Study Title: Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study Publication: The Lancet Oncology – January 2025 Dana-Farber Cancer Institute authors: Toni K. Choueiri, MD Summary: In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute’s…
Newswise — SAN DIEGO, Jan. 9, 2025 /PRNewswire/ — RyboDyn, Inc., has announced the discovery of a new proteome and the successful closing of a $4 million pre-seed financing round to advance its mission of targeting the dark proteome for the development of novel immunotherapies. The round was co-led by Genedant Capital and SeaX Ventures, with significant…
Newswise — ARLINGTON HEIGHTS, Ill. (Dec. 12, 2024) – Feeling like there are too many things on your checklist for the new year? If you have allergies or asthma, keeping yourself healthy and free of symptoms needs to be a priority. But it doesn’t have to be complicated. “50 million people in the United States…
